Biomarin R&D day: massive patient-to-patient variability for Hemo A | SGMO Message Board Posts

Sangamo Therapeutics, Inc.

  SGMO website

SGMO   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  136571 of 139041  at  11/17/2019 4:43:29 PM  by

TECH32


 In response to msg 136567 by  spaddy
view thread

Re: Biomarin R&D day: massive patient-to-patient variability for Hemo A

 Or the FDA could point to Sangamo and say "Why don't they have that problem??"  ;) 


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 5     Views: 240
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board






About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help Center  •  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
© 2003-2019 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...